IDEAS home Printed from https://ideas.repec.org/p/hal/journl/halshs-00163960.html
   My bibliography  Save this paper

L'accès aux traitements antisida en Afrique : une analyse de la stratégie de brevet des entreprises multinationales

Author

Listed:
  • Samira Guennif

    (CEPN - Centre d'Economie de l'Université Paris Nord (ancienne affiliation) - UP13 - Université Paris 13 - CNRS - Centre National de la Recherche Scientifique)

  • Claude Mfuka

    (CEPN - Centre d'Economie de l'Université Paris Nord (ancienne affiliation) - UP13 - Université Paris 13 - CNRS - Centre National de la Recherche Scientifique)

Abstract

According to Attaran and Gillespie-White (2001), there is no link between patents and poor access to HIV/AIDS treatments in Africa since multinationals patent a few. Nevertheless, the authors admit that multinationals patent a lot in South Africa and specific treatments in Africa. This paper shows that rule and exceptions are part of the multinationals' offensive patenting strategy. Multinationals use patenting to erect entry barriers towards southern generics producers. As a result, this strategy impedes access to medicines and hinders the industrial development of southern generics producers.

Suggested Citation

  • Samira Guennif & Claude Mfuka, 2005. "L'accès aux traitements antisida en Afrique : une analyse de la stratégie de brevet des entreprises multinationales," Post-Print halshs-00163960, HAL.
  • Handle: RePEc:hal:journl:halshs-00163960
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:halshs-00163960. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.